Kate Sillitoe is the Global Senior Scientific Communications Director for breast cancer at Roche. With a robust background in medical writing, Kate previously held roles at Health Interactions, including Principal Medical Writer and Editorial Team Leader. Kate's academic journey includes a PhD in Biochemistry from the University of Liverpool, complemented by postdoctoral research positions at both the University of Liverpool and the University of Manchester. Their expertise in scientific communications strengthens Roche’s initiatives in breast cancer research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices